Sandra Susanibar-Adaniya

Targets

• CCR5 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma.

  Blood advances, Feb 2026

• Publication

  CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

  Nature medicine, Jan 2026

• Publication

  The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

  Blood cancer journal, Nov 2025

• Publication

  Outcomes of relapse after teclistamab therapy in multiple myeloma.

  Blood cancer journal, Nov 2025

Affiliations

• University of Pennsylvania
• Abramson Cancer Center

Co-authors

• HLHans C LeeHow are we linked?
• MRMarco RuellaHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.